Cellular senescence and metabolic reprogramming: Unraveling the intricate crosstalk in the immunosuppressive tumor microenvironment
Cancer Communications · 2024-09 · 44 (9) · 929-966
DOI: 10.1002/cac2.12591 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Communications, online erschienen am 12.07.2024. Verfasst von Fusheng Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, The Fourth Affiliated Hospital of China Medical University, Shenyang, Liaoning, P. R. China. Hauptthemen laut MEDLINE: Tumor Microenvironment, Cellular Senescence, Neoplasms. Die Arbeit wurde bisher 94-mal zitiert (Crossref) und nennt 345 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Grants from the Liaoning Nature Science Foundation of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
The intrinsic oncogenic mechanisms and properties of the tumor microenvironment (TME) have been extensively investigated. Primary features of the TME include metabolic reprogramming, hypoxia, chronic inflammation, and tumor immunosuppression. Previous studies suggest that senescence‐associated secretory phenotypes that mediate intercellular information exchange play a role in the dynamic evolution of the TME. Specifically, hypoxic adaptation, metabolic dysregulation, and phenotypic shifts in immune cells regulated by cellular senescence synergistically contribute to the development of an immunosuppressive microenvironment and chronic inflammation, thereby promoting the progression of tumor events. This review provides a comprehensive summary of the processes by which cellular senescence regulates the dynamic evolution of the tumor‐adapted TME, with focus on the complex mechanisms underlying the relationship between senescence and changes in the biological functions of tumor cells. The available findings suggest that components of the TME collectively contribute to the progression of tumor events. The potential applications and challenges of targeted cellular senescence‐based and combination therapies in clinical settings are further discussed within the context of advancing cellular senescence‐related research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of General Surgery, The Fourth Affiliated Hospital of China Medical University, Shenyang, Liaoning, P. R. China.
- Department of Hepatobiliary and Pancreatic Surgery, Peking University First Hospital, Beijing, P. R. China.
- Department of Radiology, The Fourth Affiliated Hospital of China Medical University, Shenyang, Liaoning, P. R. China.
- Outpatient Department, The Fourth Affiliated Hospital, China Medical University, Shenyang, Liaoning, P. R. China.
ORCID-Profile: Xiaofeng Jiang
Förderung
- Grants from the Liaoning Nature Science Foundation of China
- National Natural Science Foundation of China
Zitieren
APA
Zhang, F., Guo, J., Yu, S., Zheng, Y., Duan, M., Zhao, L., Wang, Y., Yang, Z., & Jiang, X. (2024). Cellular senescence and metabolic reprogramming: Unraveling the intricate crosstalk in the immunosuppressive tumor microenvironment. Cancer Communications, 44(9), 929-966. https://doi.org/10.1002/cac2.12591
Vancouver
Zhang F, Guo J, Yu S, Zheng Y, Duan M, Zhao L, et al. Cellular senescence and metabolic reprogramming: Unraveling the intricate crosstalk in the immunosuppressive tumor microenvironment. Cancer Communications. 2024;44(9):929-966. doi:10.1002/cac2.12591
BibTeX
@article{Zhang2024,
author = {Zhang, Fusheng and Guo, Junchen and Yu, Shengmiao and Zheng, Youwei and Duan, Meiqi and Zhao, Liang and Wang, Yihan and Yang, Zhi and Jiang, Xiaofeng},
title = {Cellular senescence and metabolic reprogramming: Unraveling the intricate crosstalk in the immunosuppressive tumor microenvironment},
journal = {Cancer Communications},
year = {2024},
volume = {44},
number = {9},
pages = {929--966},
doi = {10.1002/cac2.12591}
}
EUVIMED